Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients-Reference-Cited by-同舟云学术

Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients

Published:2022-02 Issue: Volume:19 Page:100405
ISSN:2666-3546
Container-title:Brain, Behavior, & Immunity - Health
language:en
Short-container-title:Brain, Behavior, & Immunity - Health

Author:

Iglesias-González Maria^ORCID,Boigues Marc,Sanagustin David,Giralt-López Maria^ORCID,Cuevas-Esteban Jorge,Martínez-Cáceres Eva,Díez-Quevedo Crisanto^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference46 articles.

1. Interleukin 6 is required for the development of collagen-induced arthritis;Alonzi;J. Exp. Med.,1998

2. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo;Atreya;Nat. Med.,2000

3. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study;Benros;JAMA Psychiatry,2013

4. The bidirectional relationship of depression and inflammation: double trouble;Beurel;Neuron,2020

5. Role of inflammation in the development of neuropsychiatric symptom domains: evidence and mechanisms;Capuron;Curr. Top. Behav. Neurosci.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychiatric manifestations of hospitalized patients with coronavirus disease 2019 during the second wave in Egypt;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-09-12

2. Evaluación de síntomas de COVID-19 en pacientes hospitalizados a través del cuestionario ESAS-r(es);Revista Mexicana de Anestesiología;2024

3. Interaktion von körperlichen Veränderungen und psychischen Störungen bei COVID-19. Ein Scoping Review;neuropsychiatrie;2023-12-06

4. Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following COVID-19 infection: A randomized, double-blind, placebo-controlled trial;Journal of Psychosomatic Research;2023-11

5. COVID-19 enfeksiyonu geçiren bireylerde altı ay içinde görülen ruhsal bozukluklar;Cukurova Medical Journal;2023-09-30